Invitrogen Shares Rise 10 Percent | GenomeWeb
Shares of Invitrogen gained 10 percent over the five-day trading period ended Tuesday, following on last week’s report that the firm’s third-quarter revenues rose 11 percent year over year (see BioCommerce Week 10/31/2007).
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.